Biotech stocks are surging. How investors can play the new drug innovation boom
CNBC

Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Summary from CNBC
Read the full story on CNBCFollow













